HKIMG
GMED icon

Hutchens & Kramer Investment Management Group’s Globus Medical GMED Stock Holding History

Hutchens & Kramer Investment Management Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,997
Closed -$228K – 115
2022
Q1 		$228K Hold
2,997
– – 0.13% 111
2021
Q4 		$207K Buy
+2,997
New +$218K 0.13% 115

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Hutchens & Kramer Investment Management Group's GMED Position: Q2 2022 in Review

Hutchens & Kramer Investment Management Group sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 2,997 shares — an estimated $228K sold.

Hutchens & Kramer Investment Management Group first reported a position in GMED in Q4 2021 and held it in 2 quarters. The position peaked at $228K in Q1 2022. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

  • Hutchens & Kramer Investment Management Group reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
  • Hutchens & Kramer Investment Management Group sold 2,997 Globus Medical shares in Q2 2022, an estimated $228K.
  • Hutchens & Kramer Investment Management Group first reported a position in Globus Medical in Q4 2021 and held it in 2 quarters.
  • Hutchens & Kramer Investment Management Group's Globus Medical position peaked at $228K in Q1 2022.
  • 364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on Hutchens & Kramer Investment Management Group's 13F filing for Q2 2022, filed 15 Aug 2022.